223
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Disseminated fusariosis in immunocompromised children: a case series and review of literature

, , , ORCID Icon, , , & show all
Pages 519-527 | Received 15 Sep 2020, Accepted 17 Dec 2020, Published online: 10 Feb 2021

References

  • Nucci F, Nouér S, Capone D, Anaissie E, Nucci M. Fusariosis. Semin Respir Crit Care Med. 2015;36(5):706–14.
  • Kobayashi R, Hori D, Sano H, Suzuki D, Kishimoto K, Kobayashi K. Risk factors for invasive fungal infection in children and adolescents with hematologic and malignant diseases: a 10-year analysis in a single institute in Japan. Pediatr Infect Dis J. 2018;37(12):1282–5.
  • White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: PCR Protocols [Internet]. Elsevier; 1990. p. 315–22.
  • O'donnell K, Kistler H C, Cigelnik E, Ploetz R C. Multiple evolutionary origins of the fungus causing Panama disease of banana: Concordant evidence from nuclear and mitochondrial gene genealogies. Proceedings of the National Academy of Sciences. 1998;95(5):2044–9. doi:https://doi.org/10.1073/pnas.95.5.2044.
  • CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. 3rd ed. CLSI standard M38. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
  • Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev. 1994;7(4):479–504.
  • Atalla A, Garnica M, Maiolino A, Nucci M. Risk factors for invasive mold diseases in allogeneic hematopoietic cell transplant recipients. Transpl Infect Dis. 2015;17(1):7–13.
  • McCarthy M, Katragkou A, Iosifidis E, Roilides E, Walsh T. Recent Advances in the Treatment of Scedosporiosis and Fusariosis. J Fungi. 2018;4(2):73.
  • Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL, Cornet M, Greene J, Herbrecht R, Lacroix C, Grenouillet F, Raad I, Sitbon K, Troke P. French Mycoses Study Group. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother. 2010;54(10):4446–50.
  • Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect. 2014;20:27–46.
  • Al-Hatmi AMS, Bonifaz A, Ranque S, Sybren de Hoog G, Verweij PE, Meis JF. Current antifungal treatment of fusariosis. Int J Antimicrob Agents. 2018;51(3):326–32.
  • Perfect JR, Cornely OA, Heep M, Ostrosky-Zeichner L, Mullane KM, Maher R, et al. Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: challenges and lessons of the VITAL trial. Mycoses. 2018;61(7):420–9.
  • Spader TB, Venturini TP, Rossato L, Denardi LB, Cavalheiro PB, et al. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium. Rev Iberoam Micol. 2013;30(3):200–4.
  • Liu JY, Chen WT, Ko BS, Yao M, Hsueh PR, Hsiao CH, Kuo YM, Chen YC. Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: a case report and literature review. Med Mycol. 2011;49(8):872–8.
  • Cho CT, Vats TS, Lowman JT, Brandsberg JW, Tosh FE. Fusarium solani infection during treatment for acute leukemia. J Pediatr. 1973;83(6):1028–31.
  • Blazar BR, Hurd DD, Snover DC, Alexander JW, McGlave PB. Invasive Fusarium infections in bone marrow transplant recipients. Am J Med. 1984;77(4):645–51.
  • Chaulk CP, Smith PW, Feagler JR, Verdirame J, Commers JR. Fungemia due to Fusarium solani in an immunocompromised child. Pediatr Infect Dis J. 1986;5(3):363–6.
  • Richardson SE, Bannatyne RM, Summerbell RC, Milliken J, Gold R, Weitzman SS. Disseminated Fusarial Infection in the Immunocompromised Host. Rev Infect Dis. 1988;10(6):1171–81.
  • Venditti M, Micozzi A, Gentile G, Polonelli L, Morace G, Bianco P, et al. Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis. 1988;10(3):653–60.
  • Barrios NJ, Kirkpatrick DV, Murciano A, Stine K, Van Dyke RB, Humbert JR. Successful treatment of disseminated fusarium infection in an immunocompromised child. J Pediatr Hematol Oncol. 1990;12(3):319–24.
  • Agamanolis D, Kalwinsky D, Krill Jr C, Dasu S, Halasa B, Galloway P. Fusarium Meningoencephalitis in a Child with Acute Leukemia. Neuropediatrics. 1991;22(02):110–2. doi:https://doi.org/10.1055/s-2008-1071428.
  • Alvarez-Franco M, Reyes-Mugica M, Paller AS. Cutaneous Fusarium infection in an adolescent with acute leukemia. Pediatr Dermatol. 1992;9(1):62–5.
  • Ammari LK, Puck JM, McGowan KL. Catheter-related Fusarium solani Fungemia and pulmonary infection in a patient with leukemia in remission. Clin Infect Dis. 1993;16(1):148–50.
  • Repiso T, Garcıa-Patos V, Martin N, Creus M, Bastida P, Castells A. Disseminated fusariosis. Pediatr Dermatol. 1996;13(2):118–21.
  • Patterson TS, Barton LL, Shehab ZM, Hutter JJ. Amphotericin B lipid complex treatment of a leukemic child with disseminated Fusarium solani infection. Clin Pediatr (Phila). 1996;35(5):257–60.
  • Bleggi-Torres LF, de Medeiros BC, Neto JZ, Loddo G, Telles FQ, de Medeiros CR, et al. Disseminated Fusarium sp. infection affecting the brain of a child after bone marrow transplantation. Bone Marrow Transplant. 1996;18(5):1013–15.
  • Mangini C, Camargo B d. Fungal infection due to fusarium (spp) in children with refractory hematologic malignancies. Med Pediatr Oncol. 1999;32(2):149–50. doi:https://doi.org/10.1002/(SICI)1096-911X(199902)32:2<149::AID-MPO16>3.0.CO;2-6.
  • Taçyildiz N, Yavuz G, Unal E, Gözdasoğlu S, Ertem M, Aysev D. Fungal infection from Fusarium spp. in children with refractory hematologic malignancies. Med Pediatr Oncol. 1999;33(6):596–7.
  • Ariffin H, Ariffin W, Mohamed M, Arasu A, Peng LH. Management of systemic Fusarium infection in children with leukemia. Med Pediatr Oncol. 1999;33(6):598–9.
  • Nigro L L, Cataldo A D, Ragusa R. Successful treatment ofFusarium (Spp.) infection in a child with acute lymphoblastic leukemia. Med Pediatr Oncol. 2000;34(5):356–7. doi:https://doi.org/10.1002/(SICI)1096-911X(200005)34:5<356::AID-MPO8>3.0.CO;2-T.
  • Okada H, Hamatani S, Kondo M, Imai T, Itoh S, Isobe K, et al. Successful treatment of disseminated Fusarium infection in an infant with leukemia. Int J Hematol. 2000;72(4):494–8.
  • Sridhar H, Subramanyam JR, Appaji L, Shafiulla M, Vijaykumar BR. Fusarium solani fungemia in a patient with acute lymphoblastic leukemia. Indian J Cancer. 2001;38(1):19–21.
  • Yücesoy M, Ergon MC, Oren H, Gülay Z. [Case report: a Fusarium fungaemia]. Mikrobiyol Bul. 2004;38(3):265–71.
  • Kivivuori S-M, Hovi L, Vettenranta K, Saarinen-Pihkala UM. Invasive fusariosis in two transplanted children. Eur J Pediatr [Internet]. 2004. [cited 2020 May 21], Available from: http://link.springer.com/https://doi.org/10.1007/s00431-004-1530-x
  • Chi C-C, Wang S-H. Disseminated cutaneous Fusarium moniliforme infections in a leukemic child. Int J Dermatol. 2007;46(5):487–9.
  • Vagace J-M, Sanz-Rodriguez C, Casado M-S, Alonso N, Garcia-Dominguez M, de la Llana FG, et al. Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report. BMC Infect Dis. 2007;7(1):40.
  • Tezcan G, Ozhak-Baysan B, Alastruey-Izquierdo A, Ogunc D, Ongut G, Yildiran ST, et al. Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation. J Clin Microbiol. 2009;47(1):278–81.
  • Marcoux D, Jafarian F, Joncas V, Buteau C, Kokta V, Moghrabi A. Deep cutaneous fungal infections in immunocompromised children. J Am Acad Dermatol. 2009;61(5):857–64.
  • Cooke NS, Feighery C, Armstrong DKB, Walsh M, Dempsey S. Cutaneous Fusarium solani infection in childhood acute lymphoblastic leukaemia. Clin Exp Dermatol. 2009;34(5):e117–e119.
  • Cesaro S, Marinello S, Alessia B, Alaggio R, Rossi L, Toffolutti T, Putti MC, Gamba P. Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approach. Mycoses. 2010;53(2):181–5.
  • Gurusidappa S, Mamatha H. Fusarial skin lesion in immunocompromised. Indian J Cancer. 2011;48(1):116–17.
  • Zegarra-Linares R, Wang ZJ, Lephart P, Poulik J, Rongkavilit C. A knee ulcer in a teenager with acute myeloid leukemia. Pediatr Infect Dis J. 2012;31(10):1100.
  • Morel LN, Cid PM, De Celada RMA, Rodríguez MF, Beato M, Arias ÁG, Laguna RDL. Disseminated fusariosis in a pediatric population. Pediatr Dermatol. 2013;30(6):e255–e256.
  • Schwartz KL, Sheffield H, Richardson SE, Sung L, Morris SK. Invasive fusariosis: a single pediatric center 15-year experience. J Pediatric Infect Dis Soc. 2015;4(2):163–70.
  • Litvinov N, da Silva MTN, van der Heijden IM, Graça MG, Marques de Oliveira L, Fu L, et al. An outbreak of invasive fusariosis in a children's cancer hospital. Clin Microbiol Infect. 2015;21(3):268.e1–e7.
  • Das K, Bhattacharyya A, Chandy M, Roy M, Goel G, Hmar L, Chakrabarti A. Infection Control Challenges of Infrequent and Rare Fungal Pathogens: Lessons from Disseminated Fusarium and Kodamaea ohmeri Infections. Infection Control & Hospital Epidemiology. 2015;36(7):866–868.
  • Hassler A, Lieb A, Seidel D, Cesaro S, Greil J, Klimko N, et al. Disseminated fusariosis in immunocompromised children-analysis of recent cases identified in the global fungiscope registry. Pediatr Infect Dis J. 2017;36(2):230–1.
  • Arnoni MV, Paula CR, Auler ME, Simoes CCN, Nakano S Szeszs MW, et al. Infections caused by Fusarium species I pediatric cancer patients and review of published literature. Mycopathologia. 2018;183(6):941–9.
  • Uemura S, Tamura A, Yamamoto N, Saito A, Nakamura S, Fujiwara T, et al. Successful Combination Therapy of Liposomal Amphotericin B and Caspofungin for Disseminated Fusariosis in a Pediatric Patient With Acute Lymphoblastic Leukemia: Pediatr Infect Dis J. 2018;37(10):e251–3.
  • Olivares R, Luppi M, Díaz MC. Tratamiento exitoso de una fusariosis diseminada en un paciente neutropénico febril con terapia antifúngica combinada de voriconazol más anfotericina B deoxicolato. Rev Chil Infectol. 2018;35(4):448–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.